Skip to main content
Top
Published in: Sleep and Breathing 2/2007

Open Access 01-06-2007 | Original Article

Position paper on the use of mandibular advancement devices in adults with sleep-related breathing disorders

A position paper of the German Society of Dental Sleep Medicine (Deutsche Gesellschaft Zahnaerztliche Schlafmedizin, DGZS)

Authors: Susanne Schwarting, Ulrich Huebers, Markus Heise, Joerg Schlieper, Andreas Hauschild

Published in: Sleep and Breathing | Issue 2/2007

Login to get access

Abstract

Custom-made mandibular advancement devices are an effective treatment option for snoring, upper airway resistance syndrome, and obstructive sleep apnea (OSA). Evidence-based data indicates their efficacy, and international sleep societies recommend oral appliance (OA) therapy for patients with sleep-related breathing disorders. The following position paper by the German Society of Dental Sleep Medicine (DGZS) is to guide the interdisciplinary team (sleep physician and sleep disorder dentist) in detail when to prescribe oral appliances. This position paper supports the responsible use of OA as an effective treatment option for patients with sleep-related breathing disorders. The paper advises of proper indication regarding OSA severity, body mass index (BMI), and dentition. It emphasizes the interdisciplinary approach of oral appliance therapy and suggests treatment under the guidance of dentists trained in dental sleep medicine.
Literature
1.
go back to reference American Academy of Sleep Medicine (1995) Practice parameters for the treatment of snoring and obstructive sleep apnea with oral appliances. Sleep 18:501–510 American Academy of Sleep Medicine (1995) Practice parameters for the treatment of snoring and obstructive sleep apnea with oral appliances. Sleep 18:501–510
2.
go back to reference American Academy of Sleep Medicine (2006) An American Academy of Sleep Medicine report. Practice parameters for the treatment of snoring and obstructive sleep apnea with oral appliances: an update for 2005. Sleep 29:240–243 American Academy of Sleep Medicine (2006) An American Academy of Sleep Medicine report. Practice parameters for the treatment of snoring and obstructive sleep apnea with oral appliances: an update for 2005. Sleep 29:240–243
3.
go back to reference Cartwright RD, Samelson CF (1982) The effects of a nonsurgical treatment for obstructive sleep apnea. The tongue-retaining device. JAMA 248:705–709PubMedCrossRef Cartwright RD, Samelson CF (1982) The effects of a nonsurgical treatment for obstructive sleep apnea. The tongue-retaining device. JAMA 248:705–709PubMedCrossRef
4.
go back to reference Fischer J, Mayer G, Peter J-H, Riemann D, Sitter H (2002) Leitlinie “S2” der Deutschen Gesellschaft für Schlafforschung und Schlafmedizin (DGSM). Nicht erholsamer Schlaf. Blackwell Wissenschafts–Verlag, Berlin, Wien Fischer J, Mayer G, Peter J-H, Riemann D, Sitter H (2002) Leitlinie “S2” der Deutschen Gesellschaft für Schlafforschung und Schlafmedizin (DGSM). Nicht erholsamer Schlaf. Blackwell Wissenschafts–Verlag, Berlin, Wien
5.
go back to reference Lim J, Lasserson TJ, Fleetham J, Wright J (2006) Oral appliances for obstructive sleep apnoea. Cochrane Database Syst Rev, CD004435 Lim J, Lasserson TJ, Fleetham J, Wright J (2006) Oral appliances for obstructive sleep apnoea. Cochrane Database Syst Rev, CD004435
6.
go back to reference Lim J, Lasserson TJ, Fleetham J, Wright J (2004) Oral appliances for obstructive sleep apnoea. Cochrane Database Syst Rev, CD004435 Lim J, Lasserson TJ, Fleetham J, Wright J (2004) Oral appliances for obstructive sleep apnoea. Cochrane Database Syst Rev, CD004435
7.
go back to reference Lim J, Lasserson TJ, Fleetham J, Wright J (2003) Oral appliances for obstructive sleep apnoea. Cochrane Database Syst Rev, CD004435 Lim J, Lasserson TJ, Fleetham J, Wright J (2003) Oral appliances for obstructive sleep apnoea. Cochrane Database Syst Rev, CD004435
8.
go back to reference Meyer-Ewert K, Schäfer H, Kloß W (1984) Treatment of sleep apnea by mandibular protracting device. 7th European congress of sleep research, München, p 217 Meyer-Ewert K, Schäfer H, Kloß W (1984) Treatment of sleep apnea by mandibular protracting device. 7th European congress of sleep research, München, p 217
9.
go back to reference Randerath W, Bauer M, Blau A, Fietze I, Galetke W, Hein H, Maurer JT, Orth M, Rasche R, Rühle KH, Sanner B, Stuck BA, Verse T (2006) Stellenwert der Nicht-nCPAP-Verfahren in der Therapie des obstruktiven Schlafapnoe-Syndroms. Somnologie 10:67–98 Randerath W, Bauer M, Blau A, Fietze I, Galetke W, Hein H, Maurer JT, Orth M, Rasche R, Rühle KH, Sanner B, Stuck BA, Verse T (2006) Stellenwert der Nicht-nCPAP-Verfahren in der Therapie des obstruktiven Schlafapnoe-Syndroms. Somnologie 10:67–98
Metadata
Title
Position paper on the use of mandibular advancement devices in adults with sleep-related breathing disorders
A position paper of the German Society of Dental Sleep Medicine (Deutsche Gesellschaft Zahnaerztliche Schlafmedizin, DGZS)
Authors
Susanne Schwarting
Ulrich Huebers
Markus Heise
Joerg Schlieper
Andreas Hauschild
Publication date
01-06-2007
Publisher
Springer-Verlag
Published in
Sleep and Breathing / Issue 2/2007
Print ISSN: 1520-9512
Electronic ISSN: 1522-1709
DOI
https://doi.org/10.1007/s11325-007-0116-z

Other articles of this Issue 2/2007

Sleep and Breathing 2/2007 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine